Clinical trial Recruiting at 1 site Observational Ages 18 and up

Comparing anticoagulants for platelet function analysis in hemostasis

Official title: Choice of Anticoagulant for Primary Hemostasis Studies With PFA200® (Platelet Function Analyser)

Run by Centre Hospitalier Universitaire Dijon · NCT06753838 · Data updated 2026-11-12

This study is testing whether a new type of blood collection tube can give better results for patients with bleeding disorders compared to the standard tube used for checking how well blood clots.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorCentre Hospitalier Universitaire Dijon
Academic / other
Locations1 site (Dijon)
StatusRecruiting
StartedJanuary 21, 2025
Main results expectedDecember 2025
Study endsDecember 2025
Registry record updatedSeptember 29, 2025
Trial IDNCT06753838 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults receiving hemostasis consultations who are undergoing a prescribed PFA test.

Probably not a fit

Patients who are under legal protection, pregnant, or unable to provide consent will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the effectiveness of different anticoagulants in platelet function analysis, specifically comparing conventional citrate tubes with BAPA tubes. The PFA test will be performed on patients receiving hemostasis consultations at a specialized treatment center, where blood samples will be collected using both types of tubes. The goal is to determine if the BAPA tube, which uses a different mechanism to block coagulation, yields more reliable results with less technical difficulty. This could enhance the understanding of primary hemostasis and improve patient care in bleeding disorders.

Why it matters

Potential benefit: If successful, this study could lead to more accurate assessments of platelet function, improving diagnosis and treatment for patients with bleeding disorders.

How similar studies have gone: While this approach is relatively novel, previous studies have indicated the importance of anticoagulant choice in platelet function testing, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Person having given their non-opposition
* Person of legal age
* Person receiving a haemostasis consultation at the haemophilia and haemorrhagic diseases treatment center followed by a blood sample with a PFA test prescribed by the doctor (the test is not added for the study).

Exclusion Criteria:

* persons under legal protection (curatorship, guardianship)
* persons subject to a court protection order
* pregnant, parturient or breast-feeding women
* adult incapable or unable to give consent
* minor

Where it's running

  • CHU Dijon Bourgogne
    Dijon, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.